Prevalence of antibodies to human papillomavirus (HPV) type 16 virus-like particles in relation to cervical HPV infection among college women.
about
Determinants of seropositivity among HPV-16/18 DNA positive young women.Serological cross-reactivities between antibodies to simian virus 40, BK virus, and JC virus assessed by virus-like-particle-based enzyme immunoassays.Optimization of a human papillomavirus-specific enzyme-linked immunosorbent assay.Time course of humoral and cell-mediated immune responses to human papillomavirus type 16 in infected women.Risk of newly detected infections and cervical abnormalities in women seropositive for naturally acquired human papillomavirus type 16/18 antibodies: analysis of the control arm of PATRICIA.Prevalence of anti-human papillomavirus type 16, 18, 31, and 58 virus-like particles in women in the general population and in prostitutes.Seroprevalence of human papillomavirus types 6, 11, 16 and 18 in Chinese women.Determinants of baseline seroreactivity to human papillomavirus type 16 in the Ludwig-McGill cohort study.A novel HPV 16 L1-based chimeric virus-like particle containing E6 and E7 seroreactive epitopes permits highly specific detection of antibodies in patients with CIN 1 and HPV-16 infection.Serological detection of human papillomavirus type 16 infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.Human papillomavirus 16/18 seroprevalence in unvaccinated women over 30 years with normal cytology and with high grade cervical abnormalities in Australia: results from an observational studyCharacteristics of HPV-specific antibody responses induced by infection and vaccination: cross-reactivity, neutralizing activity, avidity and IgG subclassesHuman papillomavirus-specific antibody status in oral fluids modestly reflects serum status in human immunodeficiency virus-positive individuals.Polymer-based enzyme-linked immunosorbent assay using human papillomavirus type 16 (HPV16) virus-like particles detects HPV16 clade-specific serologic responsesHPV Serology Testing Confirms High HPV Immunisation Coverage in England.A human monoclonal antibody against HPV16 recognizes an immunodominant and neutralizing epitope partially overlapping with that of H16.V5Interlaboratory agreement among results of human papillomavirus type 16 enzyme-linked immunosorbent assays.Age-specific human papillomavirus antibody and deoxyribonucleic acid prevalence: a global reviewHuman papillomavirus vaccination in HIV-infected women: need for increased coverage.Specificity of L1 peptides versus virus-like particles for detection of human papillomavirus-positive cervical lesions in females attending Engativa Hospital, Bogota, ColombiaProjected impact of Cervarix™ vaccination on oncogenic human papillomavirus infection and cervical cancer in the United KingdomOral manifestations of human papillomavirus infections
P2860
Q30986936-9CC8BE85-74A7-4BEF-9159-62DA402050AFQ33186315-74984FED-9263-4049-8A7A-93139AA2D900Q33943463-18FFFD1E-4588-4999-913D-45EB5F3B1C6AQ33944133-0CF5A99B-0F22-47A8-A99B-63CAB5366803Q33953881-F6E90BF1-06C3-4FCD-8963-5D5FC3995CA0Q33974260-7889EE86-C8BE-488A-835F-33020642292FQ34310582-059D9AA7-2FC6-491C-8ABE-FAED9A3E827DQ34587057-78F460C2-5604-418B-8702-4FD4638395FCQ34593100-EACE489C-002C-41D9-9040-C310B9F386A6Q34601418-836A30AD-43A4-4C5A-A198-4053CEF193BFQ34987731-F6FBACF2-C8BD-470C-8962-FE5D1E43343DQ34994905-B1310109-EB60-4DCB-99AE-2060EF1E8AB2Q34995733-F43B403E-159B-4264-8094-7A5F601A29BDQ35155632-D2FCF623-3EA6-4FAF-B646-1F56BBF88CEAQ35950913-D9738DEF-0CD9-424C-8861-9F4180720520Q36448778-DFF9048E-010B-47C3-BCE7-D1024D6EF223Q36545052-59844CF9-B70B-47EC-A473-9E0705D25845Q36609068-A0244F60-268B-4B9F-B680-FB234C6C382CQ36780952-1F646A65-964D-46B1-B509-564E665F4D35Q36957928-3C0D9613-622D-4538-BFEC-AD8F52F80B90Q37502417-F977D20A-CE78-4FB2-A598-3744691A5400Q58766185-69AAA953-4A49-4B20-A042-85FD43E48CB5
P2860
Prevalence of antibodies to human papillomavirus (HPV) type 16 virus-like particles in relation to cervical HPV infection among college women.
description
1997 nî lūn-bûn
@nan
1997 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մարտին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Prevalence of antibodies to hu ...... infection among college women.
@ast
Prevalence of antibodies to hu ...... infection among college women.
@en
type
label
Prevalence of antibodies to hu ...... infection among college women.
@ast
Prevalence of antibodies to hu ...... infection among college women.
@en
prefLabel
Prevalence of antibodies to hu ...... infection among college women.
@ast
Prevalence of antibodies to hu ...... infection among college women.
@en
P2093
P2860
P1476
Prevalence of antibodies to hu ...... infection among college women.
@en
P2093
P2860
P304
P577
1997-03-01T00:00:00Z